
|Videos|December 31, 2015
Dr. Debu Tripathy on Further Investigation Into Immunotherapies in Breast Cancer
Author(s)Debu Tripathy, MD
Debu Tripathy, MD, discusses the further investigation into immunotherapy's role in treating breast cancer.
Advertisement
Debu Tripathy, MD, chair, Breast Medical Oncology, University of Texas MD Anderson Cancer Center, discusses the further investigation into immunotherapy's role in treating breast cancer. Tripathy says while immunotherapy is effective in cancer types that already generate an immune response, breast cancer types such as triple negative responds better to standard therapy despite being immunogenic.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Early CAR T Brings Questions of Preferred Bridging in Multiple Myeloma
2
Selinexor Plus Ruxolitinib Improves Spleen Responses, Shows OS Signal in Frontline Myelofibrosis
3
ASCO 2026 Breast Cancer Highlights: Beyond the LBAs
4
Phase 3 Trial of Sacituzumab Govitecan Plus Pembrolizumab Stopped Early in First-Line mNSCLC
5






































